Skip to main content

Table 1 Demographic features of the enrolled patients

From: Beyond prediction: unveiling the prognostic power of μ-opioid and cannabinoid receptors, alongside immune mediators, in assessing the severity of SARS-CoV-2 infection

Variable

Groups

Severe patients

(N = 46)

Non-Severe patients

(N = 46)

 

Gender (N,%)

Male

Female

23(50%)

23(50%)

23(50%)

23(50%)

 

Age (N, %)

≤40

40<

10(21.7%)

36(78.26%)

10(21.7%)

22(78.26%)

 

Age (Mean ± SD)

 

47.78 ± 11.83

49.55 ± 15.67

 

Weight (Mean ± SD)

Male

Female

73.32 ± 10.32

70 ± 11.31

74.21 ± 11.65

71.42 ± 11.12

 

Fever

Yes

No

32(69.56%)

14(30.44%)

27(58.69%)

19(41.31%)

 

Dyspnea

Yes

No

26(56.52%)

20(43.48%)

24(52.17%)

22(47.83%)

 

Cough

Yes

No

36(78.26%)

10(21.7%)

25(54.34%)

24(45.46%)

 

Sore throat

Yes

No

33(71.73%)

13(28.28%)

27(58.69%)

19(41.31%)

 

Myalgia

Yes

No

31(67.39%)

15(32.61%)

21(45.65%)

25(54.35%)

 

Headache

Yes

No

20(43.48%)

26(56.52%)

17(36.95%)

29(63.04%)

 

Tiredness

Yes

No

34(73.91%)

12(26.09%)

24(52.17%)

22(47.83%)

 

Diarrhea

Yes

No

11(23.91%)

35(76.09%)

2(4.34%)

44(95.65%)

 

Vomiting

Yes

No

9(19.56%)

37(80.43%)

4(8.69%)

42(91.30%)

 
  1. ** The table presents demographic features of the enrolled patients categorized as severe (N = 46) and non-severe (N = 46) for SARS-CoV-2 infection. Gender distribution, age groups, mean age, and the presence of symptoms such as fever, dyspnea, cough, sore throat, myalgia, headache, tiredness, diarrhea, and vomiting are outlined
  2. Gender distribution shows an equal split between male and female patients in both severe and non-severe groups
  3. Age distribution indicates a higher proportion of patients aged 40 and above in both severity categories
  4. Fever, cough, sore throat, myalgia, and tiredness were common symptoms reported by patients, with varying prevalence between severe and non-severe cases
  5. Dyspnea, headache, diarrhea, and vomiting were also noted, with differences in occurrence between severe and non-severe groups
  6. Mean age was slightly higher in the non-severe group compared to the severe group
  7. These demographic features offer insights into the clinical profile of patients enrolled in the study, highlighting key characteristics relevant to disease severity assessment
  8. Analysis methods for each entry in the table include statistical tests for group comparisons and descriptive statistics for demographic variables